Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights
X Zhu, Y Ma, D Liu - Journal of hematology & oncology, 2010 - Springer
Prognostic markers, such as NPM1, Flt3-ITD, and cytogenetic abnormalities have made it
possible to formulate aggressive treatment plans for unfavorable acute myeloid leukemia …
possible to formulate aggressive treatment plans for unfavorable acute myeloid leukemia …
Predicting anti-cancer drug combination responses with a temporal cell state network model
D Sarmah, WO Meredith, IK Weber… - PLoS computational …, 2023 - journals.plos.org
Cancer chemotherapy combines multiple drugs, but predicting the effects of drug
combinations on cancer cell proliferation remains challenging, even for simple in vitro …
combinations on cancer cell proliferation remains challenging, even for simple in vitro …
Therapy of Acute Myeloid Leukemia
J El-Cheikh, R Crocchiolo - Myeloid Leukemia-Clinical Diagnosis …, 2012 - books.google.com
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults1. Over
the past twenty years, the studies on the pathogenesis and prognosis of AML have made …
the past twenty years, the studies on the pathogenesis and prognosis of AML have made …